Published in J Acquir Immune Defic Syndr on December 01, 2009
Telephone Support to Improve Adherence to Anti-HIV Medications | NCT00988442
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med (1996) 8.52
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA (2006) 7.49
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet (2006) 5.00
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr (2007) 3.38
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA (1991) 2.08
Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med (1991) 1.80
The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS (1998) 1.64
HIV multidisciplinary teams work: support services improve access to and retention in HIV primary care. AIDS Care (2002) 1.63
Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS. J Gen Intern Med (2003) 1.56
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther (2003) 1.55
Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J Gen Intern Med (2004) 1.47
A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy. Med Care (2005) 1.25
Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients. Soc Sci Med (2005) 1.24
Injecting drug users' adherence to HIV antiretroviral treatments: physicians' beliefs. AIDS Care (2000) 1.06
Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study. AIDS (2007) 1.05
The effect of hospital experience on mortality among patients hospitalized with acquired immunodeficiency syndrome in California. Am J Med (1999) 1.02
HIV antiretroviral treatment: early versus later. J Acquir Immune Defic Syndr (2005) 0.99
Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: experience from 3,126 cases in New York City in 1987. J Acquir Immune Defic Syndr (1992) 0.94
Psychological stress among hospital doctors caring for HIV patients in the late nineties. AIDS Care (2001) 0.87
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med (2015) 4.26
Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med (2011) 4.03
Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial. Lancet Infect Dis (2011) 2.82
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. Lancet Infect Dis (2013) 2.51
Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS (2007) 1.78
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction (2008) 1.76
Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon. Antivir Ther (2013) 1.68
Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Clin Infect Dis (2009) 1.65
Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol (2006) 1.63
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther (2003) 1.55
Undiagnosed HIV prevalence based on nontargeted screening in emergency departments. AIDS (2012) 1.44
Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.44
Financial barriers to HIV treatment in Yaoundé, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ (2009) 1.42
Nonadherence among HIV-infected injecting drug users: the impact of social instability. J Acquir Immune Defic Syndr (2002) 1.41
Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther (2005) 1.40
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother (2009) 1.39
Efficacy of an educational and counseling intervention on adherence to highly active antiretroviral therapy: French prospective controlled study. HIV Clin Trials (2003) 1.36
Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr (2006) 1.35
Decentralization of HIV care in Cameroon: increased access to antiretroviral treatment and associated persistent barriers. Health Policy (2009) 1.31
Access to and use of unauthorised online HIV self-tests by internet-using French-speaking men who have sex with men. Sex Transm Infect (2012) 1.29
Discrimination against HIV-infected people and the spread of HIV: some evidence from France. PLoS One (2007) 1.27
Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon (EVAL survey, ANRS 12-116). Trop Med Int Health (2008) 1.26
Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend (2006) 1.21
Adherence to antiretroviral treatment in HIV-positive patients in the Cameroon context: promoting the use of medication reminder methods. J Acquir Immune Defic Syndr (2011) 1.21
HIV disclosure and unsafe sex among HIV-infected women in Cameroon: results from the ANRS-EVAL study. Soc Sci Med (2009) 1.19
Finding a cure for HIV: will it ever be achievable? J Int AIDS Soc (2011) 1.18
Health related quality of life among both current and former injection drug users who are HIV-infected. Drug Alcohol Depend (2006) 1.18
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men. BMJ Open (2012) 1.16
Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials (2007) 1.14
Performance of HIV care decentralization from the patient's perspective: health-related quality of life and perceived quality of services in Cameroon. Health Policy Plan (2011) 1.12
Association between dietary patterns and depressive symptoms over time: a 10-year follow-up study of the GAZEL cohort. PLoS One (2012) 1.10
Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study. AIDS (2007) 1.09
Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS (2003) 1.09
Prevalence of unsafe sex with one's steady partner either HIV-negative or of unknown HIV status and associated determinants in Cameroon (EVAL ANRS12-116 survey). Sex Transm Infect (2009) 1.08
Body-Mass Index and All-Cause Mortality in US Adults With and Without Diabetes. J Gen Intern Med (2013) 1.08
Internet-using men who have sex with men would be interested in accessing authorised HIV self-tests available for purchase online. AIDS Care (2012) 1.06
Living with HIV, antiretroviral treatment experience and tobacco smoking: results from a multisite cross-sectional study. Antivir Ther (2008) 1.06
Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study. AIDS (2007) 1.05
Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS (2007) 1.05
Black-white disparities in overweight and obesity trends by educational attainment in the United States, 1997-2008. J Obes (2013) 1.04
Mapping HIV/STI behavioural surveillance in Europe. BMC Infect Dis (2010) 1.04
HIV prevalence and sexual risk behaviors associated with awareness of HIV status among men who have sex with men in Paris, France. AIDS Behav (2013) 1.02
Employment loss following HIV infection in the era of highly active antiretroviral therapies. Eur J Public Health (2005) 0.99
Expanding access to non-medicalized community-based rapid testing to men who have sex with men: an urgent HIV prevention intervention (the ANRS-DRAG study). PLoS One (2013) 0.99
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8). Int J Drug Policy (2007) 0.98
Lifecourse socioeconomic position and alcohol use in young adulthood: results from the French TEMPO cohort study. Alcohol Alcohol (2013) 0.98
Impact of diabetes on work cessation: data from the GAZEL cohort study. Diabetes Care (2011) 0.98
Emotional stress and traffic accidents: the impact of separation and divorce. Epidemiology (2004) 0.98
Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management. Drug Alcohol Depend (2008) 0.98
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther (2007) 0.98
Delayed first consultation after diagnosis of HIV infection in Cameroon. AIDS (2009) 0.98
Drug injection cessation among HIV-infected injecting drug users. Addict Behav (2004) 0.98
Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study. AIDS (2007) 0.97
Routine testing to reduce late HIV diagnosis in France. BMJ (2007) 0.96
Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France. AIDS Care (2011) 0.96
Socioeconomic differences in the impact of HIV infection on workforce participation in France in the era of highly active antiretroviral therapy. Am J Public Health (2007) 0.95
Effect of early antiretroviral therapy on sexual behaviors and HIV-1 transmission risk among adults with diverse heterosexual partnership statuses in Côte d'Ivoire. J Infect Dis (2013) 0.95
Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south. AIDS (2004) 0.94
Buprenorphine sniffing as a response to inadequate care in substituted patients: results from the Subazur survey in south-eastern France. Addict Behav (2008) 0.94
Awareness of non-occupational HIV postexposure prophylaxis among French people living with HIV: the need for better targeting. AIDS (2007) 0.93
Empowering HIV testing as a prevention tool: targeting interventions for high-risk men who have sex with men. AIDS Care (2012) 0.92
Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach. Harm Reduct J (2011) 0.92
Health-related quality of life in HIV-1-infected patients on HAART: a five-years longitudinal analysis accounting for dropout in the APROCO-COPILOTE cohort (ANRS CO-8). Qual Life Res (2007) 0.91
Barriers to HIV testing in Côte d'Ivoire: the role of individual characteristics and testing modalities. PLoS One (2012) 0.91
Individual and structural factors associated with HIV status disclosure to main partner in Cameroon: ANRS 12-116 EVAL survey, 2006-2007. J Acquir Immune Defic Syndr (2011) 0.91
Multiple discriminations experienced by people living with HIV in France: results from the ANRS-Vespa2 study. AIDS Care (2014) 0.90
Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int (2014) 0.90
Unsafe sex with casual partners and quality of life among HIV-infected gay men: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA). J Acquir Immune Defic Syndr (2006) 0.89
The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010. BMC Infect Dis (2010) 0.89
Temporary employment, absence of stable partnership, and risk of hospitalization or death during the course of HIV infection. J Acquir Immune Defic Syndr (2005) 0.89
Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction (2003) 0.89
A composite index for total hip arthroplasty in patients with hip osteoarthritis. J Rheumatol (2002) 0.88
Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices. BMJ Open (2011) 0.88
Harmful alcohol consumption and patterns of substance use in HIV-infected patients receiving antiretrovirals (ANRS-EN12-VESPA Study): relevance for clinical management and intervention. AIDS Care (2010) 0.88